Biochemistry Flashcards
Histones
They are rich in lysine and arginine allowing them to bind negatively charged DNA. H1 hinds to the nucleosome and to linker DNA, thereby stabilizing the chromatin fiber. In mitosis, DNA condenses to form chromosomes. DNA and histone synthesis occurs during S phase.
Heterochromatin
Condensed, appears darker on EM. Transcriptionally inactive and sterically inaccessible. HeteroChromatin= highly condensed. Barr bodies are heterochromatin.
Euchromatin
It is less condensed, appears lighter on EM. Transcriptionally active and sterically accessible. Eu=true, truly transcribed.
DNA methylation
Template strand cytosine and adenine are methylated in DNA replication, which allows mismatch repair enzymes to distinguish between old and new strands in prokaryotes. DNA methylation at CpG islands represses transcription. CpG Methylation Makes DNA Mute.
Histone methylation
It usually reversibly represses DNA transcription, but can activate it in some cases depending on methylation location. Histone Methylation Mostly Makes DNA Mute.
Histone acetylation
Relaxes DNA coiling, allowing for transcription. Histone Acetylation makes DNA Active.
Nucleotides
Base plus deoxyribose plus phosphaTe (neucleoTide); it can be linked by 3’-5’ phosphodiester bond to another nucleotide. PURines (A, G) have two rings (PURe As Gold). PYrimidines (C, T, U) have 1 ring (CUT the PY). Thymine has a methyl group (THYmine has a meTHYl). Deamintation of cytosine makes uracil. Uracilis found in RNA, thymine in DNA. G-C bound has three H bonds and is stronger than A-T bond, which has two H bonds. An increase in G-C content causes there to be a higher melting temperature of DNA.
Nucleoside
Base plus deoxyribose (Sugar=nucleoSide)
Purine synthesis
Amino acids necessary for purine synthesis (GAG): Glycine, Aspartate, Glutamine. Purine bases are synthesized starting with the activation of Ribose-5-phosphate by PRPP synthetase to create 5’-Phosphoribosyl-1’-pyrophosphate (PRPP). IMP is converted to adenosine monophosphate (AMP) or guanine monophosphate (GMP). The synthesis of AMP requires GTP and Aspartate, and the synthesis of GMP requires ATP and Glutamine. AMP and GMP are phosphorylated to ADP/GDP or ATP/GTP and used in energy-requiring processes or RNA synthesis. Ribonucleotide reductase reduces the ribose base of ADP and GDP to dADP and dGDP, respectively, then dADP and dGDP phosphorylated to dATP and dGTP for use in DNA synthesis. Ribonucleotide reductase only works on diphosphate nucleotide.
Pyrimidine synthesis
The first reaction in pyrimidine synthesis is: Glutamine + CO2 conversion into Carbamoyl phosphate. This reaction is catalyzed by carbamoyl phosphate synthetase 2. Note that this is different from carbamoyl phosphate synthetase I used in the urea cycle. Following three additional reactions orotic acid is formed. Orotic acid formation requires aspartate and glutamine. Orotic acid + PRPP conversion into UMP. This reaction is catalyzed by UMP synthase. UMP is phosphorylated to UDP, then to UTP, then in a reaction with glutamine, UTP is converted to CTP.
Mycophenolic acid and ribavirin
Mycophenolic acid and ribavirin are reversible inhibitors of IMP dehydrogenase, an enzyme required for GMP synthesis from IMP. These drugs affect rapidly proliferating cell types, such as immune cells, for treatment of autoimmune diseases as well as prevention of transplant rejection.
Hydroxyurea
Hydroxyurea inhibits ribonucleotide reductase decreasing deoxyribonucleotide synthesis and, in turn, DNA replication and is used in treatment of chronic myelogenous leukemia (CML).
Thymidylate synthase
Thymidylate synthase, which requires methylene-THF as a cofactor, methylates dUMP to produce thymidine monophosphate (dTMP). dTMP is phosphorylated to dTTP and used in DNA synthesis.
5-flurouracil (5-FU)
5-flurouracil (5-FU) irreversibly inhibits thymidylate synthase and is used in treatment of breast and colon cancers.
Methotrexate (MTX)
Methotrexate (MTX), a folate analogue, competitively inhibits dihydrofolate reductase, an enzyme required for activation of methylene tetrahydrofolate and is used as an anticancer drug.
Trimethoprim (TMP)
Trimethoprim (TMP) inhibits bacterial dihydrofolate reductase and is used as an antibiotic drug.
Carbamoyl phosphate synthetase II
The first step of pyrimidine synthesis. Converts glutamine and CO2 into carbamoyl phosphate.
Ribonucleotide reductase
It is apart of the pyrimidine synthesis. Converts UDP into dUDP, which is apart of synthesizing dTMP. This enzyme is inhibited by hydroxyurea.
Thymidylate synthase
It converts dUMP into dTMP. This reaction requires THF, which gets converted into DHF. It is inhibited by 5-FU.
Dihyrofolate reductase
Converts DHF into THF, which is needed into dTMP synthesis. It is inhibited by MTX, TMP, and pyrimethamine.
Phosphoribosyl pyrophosphate (PRPP) synthetase
It converts ribose 5-P into PRPP, which is needed for pyrimidine and purine synthesis (first step).
Purine salvage pathway
Purine salvage is the process of recycling purines acquired from normal cell turn-over, or obtained in the diet, and converting them into nucleoside triphosphates that can be used again in the body. The three free purine bases are adenine, guanine, and hypoxanthine. The primary enzymes involved in purine salvage are HGPRT (hypoxanthine-guanine phosphoribosyltransferase) and APRT (adenine phosphoribosyltransferase). In addition to purine bases, salvage enzymes require the substrate 5-phosphoribosyl 1-pyrophosphate (PRPP). Purine salvage is separated further into two separate pathways: guanine and hypoxanthine salvage and adenine salvage
Guanine and hypoxanthine salvage
Guanine is converted to GMP via the enzyme HGPRT: Guanine + PRPP is converted into GMP + PP (pyrophosphate). Hypoxanthine is converted to IMP via the enzyme HGPRT: Hypoxanthine + PRPP is converted to IMP (apart of purine synthesis) + PP
Adenine salvage pathway
Adenine is converted to AMP via the enzyme APRT: Adenine + PRPP is converted into AMP + PP.